Tissue factor inhibition and clinical trial results of tissue factor pathway inhibitor in sepsis.
about
Bench-to-bedside review: functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsisRecent acquisitions in the pathophysiology, diagnosis and treatment of disseminated intravascular coagulation.Host defense peptides of thrombin modulate inflammation and coagulation in endotoxin-mediated shock and Pseudomonas aeruginosa sepsisNew and emerging therapies for sepsis.Clinical significance of expression of tissue factor and tissue factor pathway inhibitor in ulcerative colitisRole of tissue factor and protease-activated receptors in a mouse model of endotoxemia.The loss of homeostasis in hemostasis: new approaches in treating and understanding acute disseminated intravascular coagulation in critically ill patientsAnticoagulants for acute respiratory distress syndrome: can they work?M type 1 and 3 group A streptococci stimulate tissue factor-mediated procoagulant activity in human monocytes and endothelial cells.Drotrecogin alfa (activated): a novel therapeutic strategy for severe sepsis.Inflammation and coagulation: implications for the septic patient.Adult respiratory distress syndrome: do selective anticoagulants help?Tissue factor and tissue factor pathway inhibitor.The Levels of Tissue Factor Pathway Inhibitor in Sepsis Patients Receiving Prophylactic Enoxaparin.Innate recognition of bacteria: potential therapeutic targets for bacterial sepsis.[Sepsis-associated Purpura Fulminans International Registry--Europe (SAPFIRE)].Lactobacillus casei modulates the inflammation-coagulation interaction in a pneumococcal pneumonia experimental model.Tissue Factor/Factor FVII Complex Inhibitors in Cardiovascular Disease. Are Things Going Well?Low ADAMTS-13 activity during hemorrhagic events with disseminated intravascular coagulation.The role of protein C in sepsis.
P2860
Q24794692-E60F2166-86A0-4CCB-87D4-EF6C2333977CQ25255548-D6B9F2B3-189A-4A01-9BFF-227522698F08Q27331817-782898C1-0EB3-4D17-A3C4-B23683785175Q33183531-684768B3-B3CE-4FDA-9F41-C1225577E5FCQ33780202-5373BE47-942A-4359-89D1-88ABE59193E4Q33815424-B25315E2-8332-41D1-9084-7D282EF26420Q34257657-1C98B097-1346-4281-BAD0-3DBC953AC6B4Q34345363-686E3624-73E2-4399-8A20-153499137253Q34851150-7E81EB1B-4137-4DD6-9887-31A3C9E7EA1CQ35059326-E7003562-7A74-4591-A2D6-64355549C906Q35127410-615B6691-C248-4BE7-8931-618F6F6F7920Q35627757-78D7AC0E-EA59-425B-BDCC-FA88FC99F1BCQ35750758-64C89278-0DB3-4083-AFD8-BB83C359A3A1Q37401331-4B30EE06-94AA-495D-BAC5-5803BC04843EQ37755268-59E2C072-C2B5-424F-9550-8C6F1A691BD4Q41687756-F11F4EC9-ABAF-4026-896F-AF3890208D84Q42227513-94FE94DD-11A2-4FF2-A768-661192CBB3E3Q42723158-6D64F09D-3D76-4B62-BDE2-2718E776DB31Q43839468-E392A543-527E-4885-9B7F-8FE69136AE0EQ46953002-57FEF230-D2F0-4376-9144-E36DAE0D715C
P2860
Tissue factor inhibition and clinical trial results of tissue factor pathway inhibitor in sepsis.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Tissue factor inhibition and c ...... r pathway inhibitor in sepsis.
@ast
Tissue factor inhibition and c ...... r pathway inhibitor in sepsis.
@en
Tissue factor inhibition and c ...... r pathway inhibitor in sepsis.
@nl
type
label
Tissue factor inhibition and c ...... r pathway inhibitor in sepsis.
@ast
Tissue factor inhibition and c ...... r pathway inhibitor in sepsis.
@en
Tissue factor inhibition and c ...... r pathway inhibitor in sepsis.
@nl
prefLabel
Tissue factor inhibition and c ...... r pathway inhibitor in sepsis.
@ast
Tissue factor inhibition and c ...... r pathway inhibitor in sepsis.
@en
Tissue factor inhibition and c ...... r pathway inhibitor in sepsis.
@nl
P1476
Tissue factor inhibition and c ...... r pathway inhibitor in sepsis.
@en
P2093
P356
10.1097/00003246-200009001-00007
P407
P433
P577
2000-09-01T00:00:00Z